Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Investigating the dynamic role of the Interleukin-17 (IL-17) family during HIV, TB and HIV/TB co-infection.
EF 2022-23
Résumé
Human immunodeficiency virus (HIV) and tuberculosis (TB) are devastating global diseases that takes millions of lives every year. In 2020, there were 37.7 million people living with HIV (PLWH), with 1.5 million new infections and causing 680,000 deaths. Currently, about 25-33% of the world’s population is infected with Mycobacterium tuberculosis (M.tb), the bacteria that causes TB. Co-infection of HIV and TB worsens the prognosis of both diseases, but how this occurs and its effects on the human immune system are unclear. It is imperative that we investigate the underlying mechanism of HIV/TB co-infection, as there is a high prevalence of co-infection in areas that are endemic to both TB and HIV. More specifically, we want to investigate the role of a family of cytokines, a type of signalling molecule that stimulates the immune system response. Interleuking-17 (IL-17), a pro-inflammatory cytokine that induces inflammatory reactions in the body, has a controversial role in HIV/TB co-infections. While some studies showed that IL-17 is crucial for combating TB infections and containing the bacteria, others show that IL-17 inhibits the killing of M.tb infected cells reducing the ability of the host to fight off the infection. By using a humanized mouse model, which are immunocompromised mice engrafted with human stem cells to produce human immune cells, we will investigate how IL-17 affects disease progression in HIV, TB and HIV/TB co-infection. We hypothesize that IL-17 is beneficial in acute HIV, TB and HIV/TB co-infection by inducing antimicrobial peptide secretion and recruiting other immune cells to the site of infection. This research project can lead to the development of new and better treatment options that improve the disease outcome of HIV, TB and co-infection.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486003
Name
Lee Victoria C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the dynamic role of the Interleukin-17 (IL-17) family during HIV, TB and HIV/TB co-infection.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aids; Co-Infection; Hiv; Humanized Mice; Il-17; Immunology; Infectious Diseases; Lungs; T Cells; Tb
Abstract
Human immunodeficiency virus (HIV) and tuberculosis (TB) are devastating global diseases that takes millions of lives every year. In 2020, there were 37.7 million people living with HIV (PLWH), with 1.5 million new infections and causing 680,000 deaths. Currently, about 25-33% of the world’s population is infected with Mycobacterium tuberculosis (M.tb), the bacteria that causes TB. Co-infection of HIV and TB worsens the prognosis of both diseases, but how this occurs and its effects on the human immune system are unclear. It is imperative that we investigate the underlying mechanism of HIV/TB co-infection, as there is a high prevalence of co-infection in areas that are endemic to both TB and HIV. More specifically, we want to investigate the role of a family of cytokines, a type of signalling molecule that stimulates the immune system response. Interleuking-17 (IL-17), a pro-inflammatory cytokine that induces inflammatory reactions in the body, has a controversial role in HIV/TB co-infections. While some studies showed that IL-17 is crucial for combating TB infections and containing the bacteria, others show that IL-17 inhibits the killing of M.tb infected cells reducing the ability of the host to fight off the infection. By using a humanized mouse model, which are immunocompromised mice engrafted with human stem cells to produce human immune cells, we will investigate how IL-17 affects disease progression in HIV, TB and HIV/TB co-infection. We hypothesize that IL-17 is beneficial in acute HIV, TB and HIV/TB co-infection by inducing antimicrobial peptide secretion and recruiting other immune cells to the site of infection. This research project can lead to the development of new and better treatment options that improve the disease outcome of HIV, TB and co-infection.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Victoria C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~